Detalles de la búsqueda
1.
Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.
Mod Rheumatol
; 34(1): 45-49, 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680420
2.
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate.
Mod Rheumatol
; 34(1): 37-44, 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680426
3.
A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs.
Mod Rheumatol
; 31(4): 783-789, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33427546
4.
Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis.
Mod Rheumatol
; 28(1): 58-65, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28681650
5.
Structurally Diverse Polyamines: Solid-Phase Synthesis and Interaction with DNA.
Chembiochem
; 16(12): 1811-9, 2015 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26193996
6.
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Arthritis Rheumatol
; 73(4): 587-595, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038062
Resultados
1 -
6
de 6
1
Próxima >
>>